Volpara Health is a leading brand that specializes in providing software solutions to combat cancer. Their mission is to save families from advanced stage cancer, and they achieve this by offering innovative products and services to healthcare providers. Their Breast Health software is designed to support clinical decision-making by providing personalized detection strategies and optimized program performance.

It includes features like the Patient Hub, which streamlines workflow with customizable patient reporting and communications, and the Scorecard, which provides essential patient risk insights for early detection. Additionally, their Risk Pathways program helps identify, track, and manage high-risk patients, while their Analytics tool allows teams to monitor their performance using automated image quality metrics. Volpara Health's software is powered by scientifically validated algorithms that assess breast tissue composition, patient risk, and imaging quality.

It is used by over 2,000 facilities and more than 5,600 technologists worldwide, impacting nearly 15 million patients annually. The software can be deployed as a standalone solution or integrated with electronic health record systems, mammography reporting systems, imaging hardware, and genetic laboratories. With rigorous security certifications, numerous patents, and regulatory registrations, Volpara Health is a trusted partner of healthcare institutions globally.

Since 2016, they have raised A$132 million and continue to make strides in cancer prevention